Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/16096| Title: | Association of MTHFR C677T Genotype With Ischemic Stroke Is Confined to Cerebral Small Vessel Disease Subtype | Austin Authors: | Rutten-Jacobs, Loes C A;Traylor, Matthew;Adib-Samii, Poneh;Thijs, Vincent;Sudlow, Cathie;Rothwell, Peter M;Boncoraglio, Giorgio;Dichgans, Martin;Meschia, James;Maguire, Jane;Levi, Christopher R;Rost, Natalia S;Rosand, Jonathan;Hassan, Ahamad;Bevan, Steve;Markus, Hugh S | Affiliation: | Austin Health, Heidelberg, Victoria, Australia Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK Department of Medical and Molecular Genetics, King's College London, London, UK Stroke and Dementia Research Centre, Department of Clinical Neuroscience, St George's University of London, London, UK KULeuven Department of Experimental Neurology and Leuven Research Institute for Neuroscience and Disease, University of Leuven, and Laboratory of Neurobiology, Vesalius Research Center, VIB, Leuven, Belgium Department of Neurology, Austin Health, Heidelberg, Victoria, Australia Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia Division of Clinical Neurosciences, Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK Stroke Prevention Research Unit, Nuffield Department of Neuroscience, University of Oxford, UK Department of Cerebrovascular Diseases, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milano, Italy Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-University Munich and Munich Cluster of Systems Neurology, SyNergy, Munich, Germany Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA School of Nursing and Midwifery, University of Newcastle, Newcastle, NSW, Australia Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia Center for Human Genetic Research and Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA Department of Neurology, Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK School of Life Science, University of Lincoln, Lincoln, UK |
Issue Date: | Mar-2016 | Date: | 2016-02-02 | Publication information: | Stroke 2016; 47(3):646-651 | Abstract: | BACKGROUND AND PURPOSE: Elevated plasma homocysteine levels are associated with stroke. However, this might be a reflection of bias or confounding because trials have failed to demonstrate an effect from homocysteine lowering in stroke patients, although a possible benefit has been suggested in lacunar stroke. Genetic studies could potentially overcome these issues because genetic variants are inherited randomly and are fixed at conception. Therefore, we tested the homocysteine levels-associated genetic variant MTHFR C677T for association with magnetic resonance imaging-confirmed lacunar stroke and compared this with associations with large artery and cardioembolic stroke subtypes. METHODS: We included 1359 magnetic resonance imaging-confirmed lacunar stroke cases, 1824 large artery stroke cases, 1970 cardioembolic stroke cases, and 14 448 controls, all of European ancestry. Furthermore, we studied 3670 ischemic stroke patients in whom white matter hyperintensities volume was measured. We tested MTHFR C677T for association with stroke subtypes and white matter hyperintensities volume. Because of the established association of homocysteine with hypertension, we additionally stratified for hypertension status. RESULTS: MTHFR C677T was associated with lacunar stroke (P=0.0003) and white matter hyperintensity volume (P=0.04), but not with the other stroke subtypes. Stratifying the lacunar stroke cases for hypertension status confirmed this association in hypertensive individuals (P=0.0002), but not in normotensive individuals (P=0.30). CONCLUSIONS: MTHFR C677T was associated with magnetic resonance imaging-confirmed lacunar stroke, but not large artery or cardioembolic stroke. The association may act through increased susceptibility to, or interaction with, high blood pressure. This heterogeneity of association might explain the lack of effect of lowering homocysteine in secondary prevention trials which included all strokes. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/16096 | DOI: | 10.1161/STROKEAHA.115.011545 | Journal: | Stroke | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/26839351 | Type: | Journal Article | Subjects: | MTHFR Cerebral small vessel disease Gentic Association Homocysteine Lacunar Stroke |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.